CClinicalTrials.gg
CompletedNCT01065480MITrainingUpdated Dec 26, 2018Results posted

Training Clinicians in Motivational Interviewing

An interventional study of Live teleconference supervision and Taped Review Supervision in Substance Abuse, sponsored by New York State Psychiatric Institute. Completed at 1 site in United States. Open to participants aged 18 Years to 75 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2018-12-26.

Sponsored by New York State Psychiatric Institute · Not applicable, Interventional, and Health services research

Phase
Not applicable
Study type
Interventional
Enrollment
91
Allocation
Randomized
Ages
18 Years to 75 Years
Sex
All
01

Study summary

This study aims to train Substance Abuse Treatment Clinicians in the use of Motivational Interviewing techniques through live supervision.

Read the detailed description

New evidence-based treatments have been slow to be adopted into the routine practice of addiction treatment, and traditional training methods are of limited effectiveness. In this study, the investigators propose to continue development of methods for training clinicians in Motivational Interviewing (MI), based on the principle of live supervision. Live supervision (supervisor and trainee seeing a patient together) is common in basic training, but rarely used in continuing education. In the initial funding period we developed Teleconference Supervision (TCS), which implements live supervision by an expert through teleconferencing technology, harnessing the principles of context-dependent learning, differential reinforcement with immediacy of feedback, and modeling. Clinicians interview standard patients at their home clinics, while Supervisors listen via telephone. The clinician wears an earpiece, through which the Supervisor provides immediate feedback and coaching designed to differentially reinforce and shape MI skills. In a randomized controlled trial with community clinicians (N= 100), TCS produced superior overall MI skill, compared to control conditions where clinicians received Workshop only training, or standard tape-based supervision. Findings were encouraging yet the proportion of clinicians achieving expert proficiency was limited, and there were trends toward loss of skill at follow-up, suggesting longer training is needed to maximize and sustain MI skill.

In the new funding period, the investigators propose to build and improve upon TCS by testing an extended model of Teleconference Supervision (TCS-Plus), which will preserve the elements of live supervision from an expert supervisor but will also provide 4 sessions of enhanced tape review supervision on a bi-weekly basis after the initial TCS training. Using telephone technology, enhanced taped review allows the Supervisor and Clinician to listen to the taped session together before discussing the session. Practice sessions will increase from 5 to 9 and be spread out from 8 to 16 weeks. Providing both TCS and enhanced tape review supervision maximizes supervision style advantages. While both offer context dependent learning, TCS provides for modeling and differential reinforcement with immediacy of feedback, and enhanced tape review provides ample time to role play and discuss technique. TCS-Plus will be compared to standard Tape Review supervision. The proposed project will be a StageI trial, intent on maximizing the gains already detected with the TCS model. The investiators will assess if TCS-Plus produces superior MI skill to standard Tape Review supervision in a randomized trial with 130 community based-clinicians. It is hoped that, if successful, TCS-Plus could be a model for remote training and supervision at community treatment programs, promoting adoption of a variety of evidence-based treatments for substance use disorders into routine practice.

02

Conditions studied

  • Substance Abuse

Keywords

  • Training
  • Substance Abuse
  • Counseling
  • Motivational Interviewing
03

In context

Substance-Related Disorders

2,124 studies on the registry are indexed under Substance-Related Disorders; 393 are open to participants now.

This study's enrollment of 91 is below the median of 108 across 1,727 interventional studies indexed under Substance-Related Disorders.

Browse Substance-Related Disorders studies →

Lead sponsor

New York State Psychiatric Institute is the lead sponsor of 425 studies on the registry; 26 are open to participants now.

Of its 50 completed or terminated interventional studies of FDA-regulated products, 45 (90%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  1. Clinician, aged 18 to 75, employed in good standing at least 50% time at a licensed substance abuse treatment program.
  2. Carries a regular caseload of patients or clients for whom he/she serves as primary therapist.
  3. Interested in learning Motivational Interviewing and willing to follow treatment guidelines and training protocol, including random assignment to groups.
  4. Willing and able to attend a 2 day workshop, to tape subsequent sessions with patients for evaluation of MI skillfulness by Training Team members and raters, and to participate in supervision, including taping of sessions for review by Training Team members and raters and/or having supervisor listen to, and comment on, live sessions.

Exclusion criteria

Exclusion Criteria:

  1. Planning to terminate employment at the current treatment program within the next six months.
  2. Has received credentialing as a Motivational Interviewing trainer, or served as a Motivational Interviewing or Motivational Enhancement Therapy therapist in a clinical trial which provided feedback on MI skill.
  3. Has received formal training in Motivational Interviewing within the last three months
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
91 participants (actual)

Study arms

  • Active comparator
    Live Teleconference Supervision

    Clinicians from participating substance abuse treatment programs receive live supervision by MI trainer via teleconference while in session with client.

    Behavioral: Live teleconference supervision

  • Active comparator
    Taped Review Supervision

    Clinicians from participating substance treatment programs audio record session with client and receive supervision after the session by MI trainer.

    Behavioral: Taped Review Supervision

Interventions

  • BehavioralLive teleconference supervision

    Participants receive live teleconference supervision during a session with a client on their use of Motivational Interviewing (MI) in the session. MI is a directive, client-centered counseling style for eliciting behavior change by helping clients to explore and resolve ambivalence. Compared with nondirective counselling, it is more focused and goal-directed. The examination and resolution of ambivalence is its central purpose, and the counselor is intentionally directive in pursuing this goal.

    Also known as: Motivational Enhancement Therapy, MI, MET

  • BehavioralTaped Review Supervision

    Participants audio record a session with a client and receive supervision after the session on their use of Motivational Interviewing during the session.

06

What researchers measure

Primary outcomes

  1. Number of Participants With MI Skillfulness

    MI skillfulness measured by the Motivational Interviewing Treatment Integrity Scale (MITI) on double coded audio recorded sessions and clinical interviews. The cumulative number of participants with MI Skillfulness at each time point assessed at 1, 8, 16, 24, and 32 weeks are reported.

    Time frame: 1,8,16, 24 and 32 weeks

07

Results

Posted Nov 6, 2017

Participant flow

Participant flow — Overall Study
MilestoneLive Teleconference SupervisionTaped Review Supervision
Started4843
Completed4843
Not completed00

Outcome measures

PrimaryNumber of Participants With MI Skillfulness

MI skillfulness measured by the Motivational Interviewing Treatment Integrity Scale (MITI) on double coded audio recorded sessions and clinical interviews. The cumulative number of participants with MI Skillfulness at each time point assessed at 1, 8, 16, 24, and 32 weeks are reported.

Time frame:
1,8,16, 24 and 32 weeks
Reported as:
Count of participants · Participants
Number of Participants With MI Skillfulness
ParticipantsLive Teleconference SupervisionTaped Review Supervision
Number of Participants With MI Skillfulness4843

Adverse events

Collected over From consent through completion of trial, an average of 4 weeks.. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Live Teleconference Supervision0/48 (0%)0/48 (0%)0/48 (0%)
Taped Review Supervision0/43 (0%)0/43 (0%)0/43 (0%)

Baseline characteristics

Age, Categorical
Age, Categorical(Participants)Live Teleconference SupervisionTaped Review SupervisionTotal
<=18 years000
Between 18 and 65 years484391
>=65 years000
Sex: Female, Male
Sex: Female, Male(Participants)Live Teleconference SupervisionTaped Review SupervisionTotal
Female292049
Male192342
Race/Ethnicity, Customized
Race/Ethnicity, Customized(Participants)Live Teleconference SupervisionTaped Review SupervisionTotal
Race/Ethnicity — White, not Hispanic121123
Race/Ethnicity — Black, not Hispanic241438
Race/Ethnicity — Hispanic121527
Race/Ethnicity — Asian or Pacific Islander022
Race/Ethnicity — American Indian or Native American000
Race/Ethnicity — Other011
Region of Enrollment
Region of Enrollment(Participants)Live Teleconference SupervisionTaped Review SupervisionTotal
United States484391
08

Study locations

1 site
  • New York State Psychiatric Institute
    New York, New York 10032, United States
09

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 26, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT01065480
Lead sponsor
New York State Psychiatric Institute
Collaborators
National Institute on Drug Abuse (NIDA)
Responsible party
Edward Nunes (Professor of Clinical Psychiatry, New York State Psychiatric Institute) — Principal investigator
First posted
Feb 9, 2010
Start date
Mar 1, 2010
Primary completion
Jun 1, 2015
Completion
Dec 1, 2015
Results posted
Nov 6, 2017
Last update
Dec 26, 2018

Study contacts

Edward V Nunes, MD
principal investigator · New York State Psychiatric Institute/Columbia University

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion